01 November 2005
Med Sci Monit 2005; 11(11): ED7-7 :: ID: 430274
Sometimes what we don’t know really can hurt us. After many discussions with colleagues around the world, Medical Science Monitor will start to carry information, which may help us realize the significance of intellectual property and how we may protect it. This information, which is general in nature given our global audience, may vary in its interpretation and implementation, depending on your country. However, it will cause us all to think about the signifi cance of what we are doing in advancing knowledge by being creative.
Regardless of what country you are in, there is a mechanism to protect intellectual property. In general, intellectual property can be defi ned as any useful technology, e.g., a drug or treatment protocol that you invented that is novel and not obvious. Note, a potential inventor should keep information relating to the intellectual property confi dential since making it public can result in a loss of potential intellectual property rights. This means that in order to protect your intellectual property you should avoid disclosing it to others both orally and in writing before it is protected. The exceptions to this rule are that you may discuss it with your employer (e.g., a university/ company/hospital offi cial), any co-inventors, and your or your employer’s lawyer. It is important to remember that any public disclosure without, for example, fi ling a patent application can result in giving away the technology.
If you plan to discuss this technology with an interested party, a confi dentiality agreement should
be in place whereby the party agrees not to use your technology except for purposes of evaluation and agrees to keep it confi dential. One major consideration regarding new intellectual property is whether the technology is important. Does it have the potential to generate revenue for its owners or provide signifi cant help to others? Many technologies are patentable (e.g., novel and non-obvious), but few generate a revenue stream. It is important to have discussions with experts that can help you make this determination. In some cases, individuals can lose the ability to obtain protection by publishing their work without even realizing that their publication discloses new intellectual property that may have monetary advantages. In other words, an individual may lose the ability to obtain patent protection simply by not communicating the technology to the appropriate experts.To help provide researchers and clinicians with valuable intellectual property information, Index Copernicus can be used to determine what types of intellectual properties exist, e.g., patents. Index Copernicus also can be used to find legal mechanisms for obtaining protection and experts who may assist in rendering legal advice regarding your technology. If you don’t know what you have – you don’t have it. Dr. Stefano is Vice Chair of the Board of Directors of the Research Foundation of the State University of New York and member of the State University of New York Patent Committee. J. Patrick Finn III, Ph.D, J.D. is a patent attorney at Fish & Richardson, P.C. and contributed to this article. One focus of his practice is obtaining world-wide patent protection for universities as well as biotech and medical device clients.
Keywords: Intellectual Property, Information Services, Biotechnology, Patents as Topic
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
Med Sci Monit 2022; 28:e939088
29 November 2022 : Clinical ResearchRetrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...
Med Sci Monit In Press; DOI: 10.12659/MSM.938647
24 November 2022 : Clinical ResearchA Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vacc...
Med Sci Monit In Press; DOI: 10.12659/MSM.938665
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Funga...
Med Sci Monit 2022; 28:e939088
05 Dec 2022 : Database AnalysisImpact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Pe...
Med Sci Monit In Press; DOI: 10.12659/MSM.937737
02 Dec 2022 : Clinical ResearchValue of Early Laparoscopic Exploration for Primary Infertile Patients with Patent Fallopian Tubes Complica...
Med Sci Monit In Press; DOI: 10.12659/MSM.938637
30 Nov 2022 : Clinical ResearchRetrospective Evaluation of Hematological and Clinical Factors Associated with 30-Day Mortality in 170 Pati...
Med Sci Monit In Press; DOI: 10.12659/MSM.938674
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996